ArticlePharmaceuticals (Basel, Switzerland)2021
Graft Preservation Solution DuraGraft
Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 12 citations in OpenAlex.
- Vein Graft Preservation During Coronary Artery Bypass Graft Surgery: Operative Techniques, Biomaterials and Advances from Tissue Engineering.Journal of functional biomaterials · 2026Review
- Effect of taurine on vascular dysfunction in an in vitro ischemia-reperfusion model of rat thoracic aorta.General thoracic and cardiovascular surgery · 2025Article
- Low Calcium-High Magnesium Krebs-Henseleit Solution Combined with Adenosine and Lidocaine Improved Rat Aortic Function and Structure Following Cold Preservation.Medicina (Kaunas, Lithuania) · 2024Article
- In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts.Scientific reports · 2024Article
- Effects of hypoxia versus ischaemia on vascular functions of isolated rat thoracic aorta: revisiting theKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023Article
- Sex-Specific Protection of Endothelial Function after Vascular Ischemia/Reperfusion Injury by the Senomorphic Agent Ruxolitinib.International journal of molecular sciences · 2023Article
- Zinc-aspirin preconditioning reduces endothelial damage of arterial grafts in a rodent model of revascularization.Frontiers in cardiovascular medicine · 2023Article
- Specific Graft Treatment Solution Enhances Vascular Endothelial Function.Reviews in cardiovascular medicine · 2022Article
- Aspirin Reduces Ischemia-Reperfusion Injury Induced Endothelial Cell Damage of Arterial Grafts in a Rodent Model.Antioxidants (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 2 countries.
Funding
Abstract
Vascular ischemia/reperfusion injury (IRI) in patients undergoing coronary artery bypass grafting can result in graft failure and the need for repeat revascularization procedures. DuraGraft
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.